Body Fat vs Visceral Fat: Key Differences

Body fat vs visceral fat is a distinction that matters far more than the number on the scales. Body fat is a broad term covering all adipose tissue in the body, whereas visceral fat is a specific, metabolically active type stored deep within the abdominal cavity, surrounding vital organs such as the liver and pancreas. Understanding the difference is clinically important: excess visceral fat is independently linked to type 2 diabetes, cardiovascular disease and metabolic syndrome, even in people whose overall weight appears healthy. This article explains what sets visceral fat apart, why it poses greater health risks, how to assess it and when to seek medical advice.

What is the difference between body fat and visceral fat?

Body fat covers all adipose tissue in the body, while visceral fat is a specific type stored deep in the abdominal cavity surrounding organs. Unlike subcutaneous fat, visceral fat releases fatty acids and hormones directly into the portal circulation, making its accumulation clinically significant.

Body fat and visceral fat are not the same thing: body fat is a broad term covering all adipose tissue in the body, while visceral fat is a specific, metabolically active type stored deep within the abdominal cavity, surrounding organs such as the liver, pancreas and intestines. The body stores fat in two main compartments. Subcutaneous fat sits just beneath the skin and can be felt when you pinch the skin at the waist or thigh. Visceral fat, by contrast, lies deeper and cannot be felt from the outside, nor can it be reliably assessed by external palpation.

Both types of fat serve biological functions. Subcutaneous fat acts as an energy reserve and provides insulation, while a small amount of visceral fat cushions and protects the abdominal organs. Problems arise when visceral fat accumulates in excess, because it behaves differently from subcutaneous fat at a cellular and hormonal level.

Visceral fat is sometimes described as "active fat" because it releases fatty acids, inflammatory proteins and hormones directly into the portal circulation, which carries blood straight to the liver.^[1][2] This proximity to vital organs is what makes its accumulation clinically significant, and it is why two people with a similar overall body weight or body mass index (BMI) can have very different health risk profiles depending on where their fat is distributed. The NHS and NICE both recognise central adiposity as a meaningful health indicator alongside BMI.^[4][7]

Why is visceral fat more dangerous to your health?

Visceral fat releases pro-inflammatory cytokines and free fatty acids into the portal vein, driving insulin resistance, atherosclerosis and systemic inflammation. It is independently linked to type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease and certain cancers.

Excess visceral fat is associated with a significantly higher risk of serious health conditions than an equivalent amount of subcutaneous fat, because of the inflammatory substances and free fatty acids it releases into the bloodstream. Research consistently links high visceral fat levels to an increased risk of type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease and metabolic syndrome.^[4][11] Evidence from bodies including the World Cancer Research Fund also links excess abdominal adiposity to an increased risk of certain cancers, including colorectal, postmenopausal breast and endometrial cancers. NICE guidance on obesity identification and management acknowledges central adiposity as an independent risk factor beyond overall weight.

The mechanism involves several pathways. Visceral fat cells are more metabolically active and more sensitive to hormones that trigger fat breakdown, releasing free fatty acids into the portal vein. This is associated with impaired insulin signalling in the liver, contributing to insulin resistance. Visceral fat also produces pro-inflammatory cytokines, including interleukin-6 and tumour necrosis factor-alpha, which are associated with low-grade systemic inflammation, a recognised driver of atherosclerosis and other chronic diseases.^[1][2] These are associations supported by research evidence; the precise causal pathways in humans continue to be studied.

Importantly, a person can have a BMI within the so-called healthy range and still carry a clinically significant amount of visceral fat. This pattern is sometimes described in the research literature as being "metabolically obese, normal weight" and is more common in people of South Asian, East Asian and Black African heritage, in whom cardiometabolic risk can occur at lower BMI thresholds. NICE guidance (including PH46) and NHS recommendations therefore advise that waist circumference and ethnicity-adjusted thresholds are considered alongside BMI when assessing health risk.^[5][6]

How can you tell how much visceral fat you are carrying?

Waist circumference is the most practical clinical indicator: NICE recommends thresholds of 94 cm in men and 80 cm in women, with lower values for certain ethnic groups. Precise measurement requires CT, MRI or DEXA scanning, which are not used routinely in NHS practice.

Waist circumference is the most practical clinical indicator of visceral fat accumulation and is recommended by NICE as part of routine cardiovascular and metabolic risk assessment. According to NHS and NICE guidance, a waist measurement above 94 cm in men or above 80 cm in women is associated with increased health risk, with thresholds of 102 cm in men and 88 cm in women indicating substantially higher risk.^[10][3] Lower thresholds apply for people of South Asian, Chinese, Japanese and South and Central American heritage, reflecting differing risk profiles at equivalent measurements; the International Diabetes Federation consensus provides specific figures for these groups. Waist circumference should be measured at the midpoint between the lower rib and the top of the hip bone (iliac crest), at the end of a normal breath out, using a flexible tape measure.

Waist-to-hip ratio and waist-to-height ratio are additional tools used in clinical and research settings. NICE guidance supports the use of a waist-to-height ratio above 0.5 as a simple indicator that central adiposity may be clinically significant. These measurements are straightforward to take at home.

More precise measurement of visceral fat requires imaging. Computed tomography (CT) and magnetic resonance imaging (MRI) can quantify visceral fat volume accurately but are not used routinely for this purpose in NHS practice; CT also involves radiation exposure, which limits its use for assessment alone. Dual-energy X-ray absorptiometry (DEXA) scanning can estimate body composition including visceral fat and is available in some specialist weight management services. Bioelectrical impedance scales, available commercially, provide an estimate of visceral fat but vary in accuracy and should be interpreted with caution rather than as a definitive measure.

What causes visceral fat to build up around your organs?

Visceral fat accumulates when energy intake exceeds expenditure, but is also driven by diets high in ultra-processed foods, physical inactivity, chronic stress, elevated cortisol, menopausal hormonal shifts, genetic predisposition and regular alcohol consumption.

Visceral fat accumulates primarily when energy intake consistently exceeds energy expenditure over time, but several biological, hormonal and lifestyle factors influence where the body preferentially stores excess fat. A diet high in ultra-processed foods, refined carbohydrates and added sugars is associated with visceral fat deposition; SACN and UK dietary guidance link high intakes of free sugars and low dietary quality to increased metabolic risk, including central adiposity. These associations are well established, though the precise mechanisms in humans are still being characterised.

Physical inactivity is a major contributing factor. Skeletal muscle is a key site of glucose uptake and metabolic activity, and reduced muscle mass or low activity levels reduce the body's capacity to use glucose efficiently. Sedentary behaviour, even in people who exercise regularly, has been independently associated with greater visceral fat accumulation in research studies.^[13]

Hormonal changes play a significant role. Cortisol, the primary stress hormone, is associated with visceral fat storage when chronically elevated, which is why prolonged psychological stress, poor sleep and conditions such as Cushing's syndrome are linked to central adiposity.^[9] The hormonal shifts of the menopause cause fat redistribution from the hips and thighs towards the abdomen in many women, increasing visceral fat even without a change in overall body weight.^[12] NHS information on both Cushing's syndrome and the menopause acknowledges these effects on body composition.

Genetics also influence individual susceptibility. Some people are predisposed to store fat viscerally rather than subcutaneously, and ethnicity affects this distribution independently of total body fat. Alcohol consumption, particularly heavy or regular drinking, is associated with increased visceral fat, as the liver prioritises alcohol metabolism over fat oxidation.

When should you speak to a GP about your body fat levels?

Speak to your GP if your waist circumference exceeds NICE risk thresholds, your BMI is 30 or above, or you have additional cardiometabolic risk factors such as raised blood pressure or blood glucose. Rapid abdominal weight gain with fatigue warrants investigation for an underlying hormonal condition.

You should speak to your GP about your body fat levels if your waist circumference exceeds the risk thresholds described above, if your BMI is 30 or above, or if you are of South Asian, Chinese, Japanese or Black African heritage and your BMI is 27.5 or above (in line with NICE PH46 guidance, which sets lower action thresholds for these groups). You should also seek advice if you have other cardiovascular or metabolic risk factors such as high blood pressure, raised blood glucose, abnormal cholesterol levels or a family history of type 2 diabetes or heart disease. These factors together indicate that a formal assessment of cardiometabolic risk is warranted.

You should also seek a GP review if you have noticed significant weight gain around your abdomen over a relatively short period. If this is accompanied by fatigue and unexplained weight gain, an underlying hormonal condition such as hypothyroidism or Cushing's syndrome may need to be investigated. If you experience increased thirst or frequent urination alongside weight changes, these can be symptoms of raised blood glucose or type 2 diabetes and should also be assessed promptly.

For people who have already been assessed and are considering structured weight management support, a range of options exists, from NHS-commissioned lifestyle programmes to specialist weight management services and, where clinically appropriate, pharmacological treatment. Access to specialist NHS weight management services depends on local Integrated Care Board (ICB) commissioning and referral pathways, so your GP is the best starting point. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where a medicine may be considered if it is clinically appropriate following assessment.

If you experience chest pain, sudden breathlessness or other symptoms that may suggest a cardiac event, call 999 immediately. For urgent but non-emergency health concerns outside GP hours, contact NHS 111. Routine concerns about weight and metabolic health are best addressed through your GP, who can arrange relevant blood tests and refer you to appropriate services.

Frequently Asked Questions